RNA Supply Chain Solutions
-
Process Chemicals For RNA Drug Manufacturing
Make use of our portfolio of raw materials required for mRNA with an integrated offering for all process steps, from plasmid DNA (pDNA) to mRNA synthesis to final formulation.
-
Vaccinia Capping System For mRNA Therapeutics
12/5/2025
Backed by over a decade of expertise in capping enzyme production, this system is a robust, scalable solution designed to support production journeys from early R&D to full-scale manufacturing.
-
mRNA Raw Materials: Supporting Your Journey To Market
12/5/2025
Implementing a quality-by-design approach for manufacturing inputs limits contamination risks and simplifies regulatory compliance. Validated processes ensure consistency when scaling operations.
-
The Most Comprehensive Supply Chain Solutions For The Life Sciences Industry
1/5/2022
Cryoport has expanded beyond just temperature-controlled logistics — it’s now the premier provider of supply chain solutions for life sciences, supporting research, clinical trials, commercial cell therapies around the world.
-
Fit-For-Purpose And GMP Grade mRNA Reagents
3/24/2025
Ensure the safety and efficacy of your mRNA therapeutics with high-quality, GMP-grade reagents from a trusted partner with a multi-tiered quality approach to deliver manufacturing certainty.
-
Plasmid DNA Manufacturing
1/31/2023
As a critical starting material in the production of many advanced therapies including viral vectors and RNA vaccines, cell and gene therapy research at any scale requires plasmid DNA manufacturing. Our specialists provide custom plasmid production that fits your project specifications. To save time and accelerate your cell and gene therapy programs, we also offer off-the-shelf, premanufactured, High Quality viral vector packaging plasmids.
-
Nanoplasmid™ Vector Platform
5/5/2026
With gene therapy advancing at a record pace, Aldevron recognizes the enormous promise your work can bring to therapeutics. We are proud to deliver a superior, modern plasmid technology to your therapeutic endeavors.
-
Vaccinia Capping System mRNA Guanylyltransferase And mRNA Methyltransferase
12/5/2025
mRNA Vaccinia Capping System: Proven. Scalable. Tailored to the needs of biopharma companies developing mRNA-based therapies.
-
Enabling mRNA Manufacturing For RNA-Based Vaccines And Therapeutics
2/9/2026
Learn about next-generation RNA polymerases that support diverse cap analog chemistries and modified nucleotides, ensuring high capping efficiency and sequence integrity for complex therapeutics.
-
T Cell Kit For mRNA On NanoAssemblr Spark
4/14/2022
The GenVoy-ILM T Cell Kit for mRNA is optimized for the delivery of mRNA into activated primary human T cells using mRNA-LNPs formulated on the NanoAssemblr Spark instrument and cartridges.